(Q54692331)

2 June 2018

title

Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients. (English)

1 reference

2 June 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

1 reference

1 reference

Tamer A Ahmed

1

1 reference

2 June 2018

John Hayslip

series ordinal

2

1 reference

2 June 2018

Markos Leggas

series ordinal

3

1 reference

2 June 2018

publication date

27 October 2013

1 reference

2 June 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

2 June 2018

volume

72

1 reference

2 June 2018

issue

6

1 reference

2 June 2018

page(s)

1369-1374

1 reference

2 June 2018

Regulation of the mevalonate pathway

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

The potential of statins as part of anti-cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Validated LC-MS/MS method for simultaneous determination of SIM and its acid form in human plasma and cell lysate: Pharmacokinetic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

Effect of simvastatin on glioma cell proliferation, migration, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2326-3

10.1007/S00280-013-2326-3

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018